ACSL4 and fatty liver disease: It is worthy to mention here that HFD-mediated reduction in hepatic ACSL4 protein levels in C57/BL6 mice occurs under conditions of excessive obesity, mild to moderate hyperglycemia, hyperinsulinemia, diabetes, and hepatic steatosis (13).